Previous studies have shown that NOX2 inhibition mitigates the harmful effects of hyperglycemia on cells (Balteau et al., 2011; Joseph et al., 2014), and inhibiting NOX2-induced oxidative stress could prevent DCM (Tang et al., 2019). Here, CYBB is linked to Hyperglycemia.